Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

RNA-seq of human cell line U2OS treated with chloroquine, amodiaquine and BMH-21


ABSTRACT: Ribosome biogenesis has emerged as a potential target for cancer therapy. We have characterize a new biological activity of the antimalarial drug amodiaquine as a inhibitor of ribosome biogenesis. Interestingly, amodiaquine retains the autophagy inhibitory activity of its analog chloroquine, but in addition, displays properties of the ribosome biogenesis inhibitor BMH-21. We performed a RNAseq analysis to identify shared and unique mechanisms of action among these drugs. Gene expression was profiled in U2OS cell line, using 24 samples divided in 4 treatment groups: Untreated, Amodiaquine, Chloroquine and BMH-21, incubated with compounds for 12 hours.

INSTRUMENT(S): Illumina HiSeq 2500

ORGANISM(S): Homo sapiens

SUBMITTER: Jiri Bartek 

PROVIDER: E-MTAB-7616 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Similar Datasets

2012-01-18 | E-GEOD-24579 | biostudies-arrayexpress
2012-01-18 | GSE24579 | GEO
2023-12-11 | PXD046662 | Pride
2023-08-04 | GSE225191 | GEO
2012-07-01 | GSE30351 | GEO
2012-06-30 | E-GEOD-30351 | biostudies-arrayexpress
2022-07-25 | GSE209582 | GEO
| PRJNA475249 | ENA
2021-11-08 | GSE188262 | GEO
| PRJEB30972 | ENA